These are research-grade compounds, not approved sleep aids, but they represent the kind of targeted approach that addresses the specific sleep-energy connection during GLP-1 therapy
But while the conversation often centers on smaller portions and lower numbers on the scale, many users quickly realize there's another side to the GLP-1 journey
Tapering semaglutide to the most effective dose: real-world evidence from a digital weight management programme (TAILGATE) by Sren Seier, Kine Stamp Larsen, Jesper Pedersen, Jorne Biccler and Henrik Gudbergsen, April 2024, European Congress on Obesity (ECO2024)
(Source: Applied Clinical Trials, 2026) Weight Loss Progress Over Time STEP-1 Trial Related at GoalBMI Wellness Semaglutide & Cardiovascular Health SELECT Trial Data Beyond weight loss, the 2023 SELECT (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity) trial established semaglutide as a cardiovascular medication a landmark finding that expanded its clinical use far beyond obesity treatment
Recommended Usage The appropriate dosage of BPC-157 and TB-500 capsules may vary depending on body weight, desired outcomes, and individual research response